BRNS — Barinthus Biotherapeutics Share News
0.000.00%
Last trade - 00:00Vaccitech rises as brokerages assign top rating
U.S. RESEARCH ROUNDUP-Cimarex Energy, Dollar General, Werewolf Therapeutics
Oxford COVID-19 vaccine tech maker Vaccitech's shares slump in Nasdaq debut
Vaccitech, startup behind Oxford COVID-19 vaccine tech, falls 20% in Nasdaq debut (updated)
Brief: Vaccitech PLC ADSS Open 19.9% below IPO Price In Nasdaq Debut
Vaccitech, startup behind Oxford COVID-19 vaccine tech, falls 20% in Nasdaq debut
NASDAQ RESUMED AT 11:59 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Vaccitech prices shares at $17 for U.S. IPO
Brief: Vaccitech Announces Pricing Of Initial Public Offering
Brief: Vaccitech PLC Quarterly Sees IPO Of Up To 6.5 Million Adss Priced To Be Between $16 And $18 Per ADS